1 - 25 of 36 results for author:"Bunting K.D." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90. Wang C., Wu L., Bulek K., Martin B.N., Zepp J.A., Kang Z., Liu C., Herjan T., Misra S., Carman J.A. et al. Nat. Immunol. 14:72-81(2013) · Mapped (11) |
| Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT. Mali R.S., Ma P., Zeng L.F., Martin H., Ramdas B., He Y., Sims E., Nabinger S., Ghosh J., Sharma N. et al. Blood 120:2669-2678(2012) · Mapped (19) |
| HIF-1alpha deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency. Du J., Chen Y., Li Q., Han X., Cheng C., Wang Z., Danielpour D., Dunwoodie S.L., Bunting K.D., Yang Y.C. Blood 119:2789-2798(2012) · Mapped (4) |
| Novel mechanism for Fc{epsilon}RI-mediated signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation and the selective influence of STAT5B over mast cell cytokine production. Pullen N.A., Barnstein B.O., Falanga Y.T., Wang Z., Suzuki R., Tamang T.D., Khurana M.C., Harry E.A., Draber P., Bunting K.D. et al. J. Biol. Chem. 287:2045-2054(2012) · Mapped (10) |
| Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24p3. Liu Z., Yang A., Wang Z., Bunting K.D., Davuluri G., Green M.R., Devireddy L.R. J. Biol. Chem. 286:20606-20614(2011) · Mapped (1) |
| A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Xu D., Wang S., Yu W.M., Chan G., Araki T., Bunting K.D., Neel B.G., Qu C.K. Blood 116:3611-3621(2010) · Mapped (9) |
| Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. Li G., Miskimen K.L., Wang Z., Xie X.Y., Tse W., Gouilleux F., Moriggl R., Bunting K.D. Leukemia 24:1397-1405(2010) · Mapped (5) |
| Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation. Friedbichler K., Kerenyi M.A., Kovacic B., Li G., Hoelbl A., Yahiaoui S., Sexl V., Mullner E.W., Fajmann S., Cerny-Reiterer S. et al. Blood 116:1548-1558(2010) · Mapped (12) |
| Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5. Li G., Wang Z., Miskimen K.L., Zhang Y., Tse W., Bunting K.D. PLoS ONE 5:e9152-e9152(2010) · Mapped (16) |
| STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Li G., Miskimen K.L., Wang Z., Xie X.Y., Brenzovich J., Ryan J.J., Tse W., Moriggl R., Bunting K.D. Blood 115:1416-1424(2010) · Mapped (11) |
| Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics. Strunk C.J., Platzbecker U., Thiede C., Schaich M., Illmer T., Kang Z., Leahy P., Li C., Xie X., Laughlin M.J. et al. Am. J. Hematol. 84:308-309(2009) · Mapped (2) |
| Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement. Wang Z., Li G., Tse W., Bunting K.D. Blood 113:4856-4865(2009) · Mapped (16) |
| IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil/mast cell progenitors in the spleen. Ohmori K., Luo Y., Jia Y., Nishida J., Wang Z., Bunting K.D., Wang D., Huang H. J. Immunol. 182:2835-2841(2009) · Mapped (12) |
| An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance. Chan E.R., Lavender H., Li G., Haviernik P., Bunting K.D., Adams M.D. Exp. Hematol. 37:276-284(2009) · Mapped (8) |
| STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Cohen P.A., Koski G.K., Czerniecki B.J., Bunting K.D., Fu X.Y., Wang Z., Zhang W.J., Carter C.S., Awad M., Distel C.A. et al. Blood 112:1832-1843(2008) · Mapped (16) |
| Hematopoiesis in mice is extremely resilient to wide variation in TIMP/MMP balance. Haviernik P., Diaz M.T., Haviernikova E., Tse W., Stetler-Stevenson W.G., Bunting K.D. Blood Cells Mol. Dis. 41:179-187(2008) · Mapped (7) |
| STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output. Li G., Wang Z., Zhang Y., Kang Z., Haviernikova E., Cui Y., Hennighausen L., Moriggl R., Wang D., Tse W. et al. Exp. Hematol. 35:1684-1694(2007) · Mapped (11) |
| Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD. Bunting K.D., Xie X.Y., Warshawsky I., Hsi E.D. Blood 110:2775-2776(2007) · Mapped (5) |
| Cited2 is required for normal hematopoiesis in the murine fetal liver. Chen Y., Haviernik P., Bunting K.D., Yang Y.C. Blood 110:2889-2898(2007) · Mapped (1) |
| Stat5 is essential for early B cell development but not for B cell maturation and function. Dai X., Chen Y., Di L., Podd A., Li G., Bunting K.D., Hennighausen L., Wen R., Wang D. J. Immunol. 179:1068-1079(2007) · Mapped (15) |
| Abnormal hematopoiesis in Gab2 mutant mice. Zhang Y., Diaz-Flores E., Li G., Wang Z., Kang Z., Haviernikova E., Rowe S., Qu C.-K., Tse W., Shannon K.M. et al. |
| Stat5 expression is required for IgE-mediated mast cell function. Barnstein B.O., Li G., Wang Z., Kennedy S., Chalfant C., Nakajima H., Bunting K.D., Ryan J.J. J. Immunol. 177:3421-3426(2006) · Mapped (18) |
| Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling. Yu W.M., Daino H., Chen J., Bunting K.D., Qu C.K. J. Biol. Chem. 281:5426-5434(2006) · Mapped (4) |
| Stat5 tetramer formation is associated with leukemogenesis. Moriggl R., Sexl V., Kenner L., Duntsch C., Stangl K., Gingras S., Hoffmeyer A., Bauer A., Piekorz R., Wang D. et al. Cancer Cell 7:87-99(2005) · Mapped (14) |
| Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation. Haviernik P., Lahoda C., Bradley H.L., Hawley T.S., Ramezani A., Hawley R.G., Stetler-Stevenson M., Stetler-Stevenson W.G., Bunting K.D. Oncogene 23:9212-9219(2004) · Mapped (5) |